 |
 |
 |
|
Pharmacokinetic Bridging with Oral Lenacapavir for Missed Subcutaneous Q6M Dosing
|
|
|
IAS 2023 july 25
Vamshi Jogiraju,1 Mark Shelton,2 Naveed Shaik,1 Dipti Bhakta,1 John Ling,1 Hui Wang,1 Hadas Dvory-Sobol,1 Martin Rhee,1 Ramesh Palaparthy,1 Renu Singh1
1Gilead Sciences, Inc., Foster City, CA, USA; 2Certara, Inc., Princeton, NJ, USA









|
|
|
 |
 |
|
|